BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ohya Y, Hayashida S, Tsuji A, Kuramoto K, Shibata H, Setoyama H, Hayashi H, Kuriwaki K, Sasaki M, Iizaka M, Nakahara O, Inomata Y. Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy. Surg Case Rep 2020;6:318. [PMID: 33301055 DOI: 10.1186/s40792-020-01078-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Colón Rodríguez A, Velasco Sánchez E, Rodríguez-Bachiller L, Díaz-Zorita B, López Baena JÁ, Álvarez Luque A, Rincón Rodríguez D, Matilla Peña AM. Neoadjuvant combined strategy to surgery based on chemoembolization and lenvatinib in hepatocellular carcinoma. Gastroenterol Hepatol 2021:S0210-5705(21)00224-7. [PMID: 34400190 DOI: 10.1016/j.gastrohep.2021.07.006] [Reference Citation Analysis]
2 Toshida K, Itoh S, Yoshizumi T, Shimagaki T, Wang H, Kurihara T, Toshima T, Nagao Y, Harada N, Hata K, Makihara Y, Watanabe H, Mori M. Retrospective evaluation of the effect of Ninjin'yoeito in hepatocellular carcinoma patients treated with lenvatinib. Surg Today 2021. [PMID: 34417867 DOI: 10.1007/s00595-021-02358-7] [Reference Citation Analysis]
3 Yamamura K, Beppu T. Conversion surgery for hepatocellular carcinoma after multidisciplinary treatment including lenvatinib. Hepatol Res 2021;51:1029-30. [PMID: 34596312 DOI: 10.1111/hepr.13691] [Reference Citation Analysis]
4 Asahi Y, Kamiyama T, Kakisaka T, Orimo T, Shimada S, Nagatsu A, Aiyama T, Sakamoto Y, Kamachi H, Taketomi A. Outcomes of reduction hepatectomy combined with postoperative multidisciplinary therapy for advanced hepatocellular carcinoma. World J Gastrointest Surg 2021; 13(10): 1245-1257 [PMID: 34754392 DOI: 10.4240/wjgs.v13.i10.1245] [Reference Citation Analysis]